Jeffrey S. Heier

This profile gathers the share dealings of Jeffrey S. Heier in Ocular Therapeutix, Inc, where the filings describe the role as board member. The record holds 15 filings, for trades running from 15 March 2019 to 2 October 2026.

The open-market side counts 2 purchases for €132k alongside 9 sales for €352k. Netting one side against the other leaves €219k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants. 2026 to date brings no purchases and 3 sales.

On 6 October 2026 came the latest disclosure, an open-market sale for €68k in Ocular Therapeutix, Inc. The most recent open-market purchase was published on 16 May 2022, 1,622 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.